Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier.
Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai Q, Chen W. · 2020
Read Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. by Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai Q, Chen W. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7003451.txt.
Introduction
Liu and co-authors review how probiotic surface parts and products protect the gut wall. Their review appeared in Microbial Cell Factories. Gut microbes strongly shape the intestinal barrier, the single cell layer that keeps gut contents out of body tissue. Friendly bacteria help hold that line.
Helpful strains include Lactobacillus, Bifidobacteria, and newer candidates such as Akkermansia muciniphila. Their surface features, including surface proteins, flagella, pili, and sugar capsules, match receptors on gut cells. Those contacts trigger signals that calm inflammation and block cell suicide, strengthening the barrier. Products the bacteria release work too: proteins, organic acids, indole, vesicles, and bacteria-killing compounds. The authors explain each route in molecular detail. Earlier reviews mixed in pathogens and the immune system; this one stays on probiotics and the barrier itself.
Catalog record
| CREATOR | Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai Q, Chen W. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier By Qing Liu, Zhiming Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Qixiao Zhai, Wei Chen Published in: Microbial Cell Factories DOI: 10.1186/s12934-020-1289-4 ABSTRACT The gut microbiota can significantly affect the function of the intestinal barrier. Some intestinal probiotics (such as Lactobacillus, Bifidobacteria, a few Escherichia coli strains, and a new generation of probiotics including Bacteroides thetaiotaomicron and Akkermansia muciniphila) can maintain intestinal epithelial homeostasis and promote health. This review first summarizes probiotics’ regulation of the intestinal epithelium via their surface compounds. Surface layer proteins, flagella, pili and capsular polysaccharides constitute microbial-associated molecular patterns and specifically bind to pattern recognition receptors, which can regulate signaling pathways to produce cytokines or inhibit apoptosis, thereby attenuating inflammation and enhancing the function of the gut epithelium. The review also explains the effects of metabolites (such as secreted proteins, organic acids, indole, extracellular vesicles and bacteriocins) of probiotics on host receptors and the mechanisms by which these metabolites regulate gut epithelial barrier function. Previous reviews summarized the role of the surface macromolecules or metabolites of gut microbes (including both probiotics and pathogens) in human health. However, these reviews were mostly focused on the interactions between these substances and the intestinal mucosal immune system. In the current review, we only focused on probiotics and discussed the molecular interaction between these bacteria and the gut epithelial barrier. BACKGROUND The gut is a diversiform microenvironment in which hundreds of types of bacteria grow [1]. Intestinal epithelial cells (IECs) are generally considered to be immune sentinels and to play a crucial role in maintaining the integrity of the host’s intestinal mucosa [2]. Structurally, the monolayer of IECs separates the mucus produced by the goblet cells and the microbiota from the underlying immune cells to form a gut epithelial barrier (Fig. 1) [3]. The intestinal epithelial barrier is thus the main defense mechanism against infection and inflammation, and the disruption of its integrity is one of the primary causes of several intestinal disorders [4], including inflammatory bowel disease, necrotizing enterocolitis, diabetes, obesity, and irritable bowel syndrome [5]. Although gut diseases have a certain relationship with factors such as diet, genetics, and the environment, it is generally believed that dysbacteriosis is the most important factor that affects the intestinal barrier [6].Fig. 1Structure, function, and probiotics of intestinal epithelial barrier. The mucus secreted by goblet cells continuously replenishes the mucosal layer that covers the intestinal epithelium, which acts as the first physical barrier against pathogenic bacteria. The symbiotic bacteria in the outer mucus layer can ferment dietary fiber into SCFAs, providing important energy sources for colonic intestinal cells and goblet cells. Paneth cells secrete a variety of antibacterial substances, such as antimicrobial peptides and Reg3γ. These antibacterial substances and secretory IgA are secreted into mucus to protect against commensal pathogens. The microorganism-associated molecular patterns (MAMPs) of probiotics can be recognized by PRRs such as TLRs, which induces the response of dendritic cells (DCs) to provide the protection on gut epithelial barrier. PRRs pattern recognition receptors, SCFAs short-chain fatty acids Probiotics are defined as “live microorganisms which when administered in adequate amounts confer a health benefit on the consumer” [7]. Commonly recognized intestinal probiotics include Lactobacillus, Bifidobacterium, Streptococcus, and a few Escherichia coli strains [1]. Recent studies have also indicated that some intestinal symbiotic bacteria such as Akkermansia muciniphila and Bacteroides thetaiotaomicron demonstrate the potency to comprise a new generation of probiotics [8, 9]. These bacteria have long been proven to regulate intestinal epithelial function by facilitating the formation of mucous layers, secreting antibacterial factors, boosting the secretion of secretory immunoglobulin A (SlgA) and competitive adhesion to intestinal epithelial cells [10, 11], and increasing tight junction formation [12]. Although these protective effects have been well documented, the underlying molecular mechanism of probiotics on the gut barrier has not been thoroughly reviewed. The surface components of probiotics, such as flagella, pili, surface layer proteins (SLPs), capsular polysaccharide (CPS), lipoteichoic acid, and lipopolysaccharide, constitute microbial-associated molecular patterns (MAMPs) [13]. They can specifically bind to pattern recognition receptors (PRRs) such as NOD-like receptors (NLRs) and toll-like receptors (TLRs) (Table 1) [14, 15], and regulate nuclear factor kappa B (NF-κB), mitogen-activated protein kinases (MAPK), peroxisome proliferator-activated receptor gamma, and other signaling pathways in IEC [16]. MAMPs also regulate a cellular protease-dependent signaling cascade to produce a variety of cytokines and chemokines that alleviate inflammation and enhance intestinal epithelial function [10, 17]. In addition, some metabolites produced by probiotics, such as secreted proteins (extracellular proteins), organic acids, indole, bacteriocins, H2O2, and NO, protect the gut’s epithelial barrier by boosting mucus secretion by goblet cells, increasing the production of antimicrobial peptides, or enhancing the expression of tight junctions (Fig. 1) [18].Table 1Examples of interactions between MAMPs of probiotics and PRRs of hostsMAMPProbioticPRRPRR locationCo-receptorSpeciesRefsSlpADC-SIGNCell membraneUnknownL. acidophilus[29]FlagellinTLR5Cell membraneUnknownE. Coli Nissle 1917[35]PiliTLR4Cell membraneMannose glycoproteinsE. Coli Nissle 1917 (type 1 pili)[42]CPSUnknownUnknownUnknownB. thetaiotaomicron[48]LTATLR2Cell membraneCD14 and CD36L. plantarum[113]PGTLR2-NOD1 (or NOD2)Cell membrane–CytoplasmicCD14L. plantarumDAP-PG[114]p40p75UnknownUnknownEGFRL. rhamnosus GG[55]IndoleTLP4Cell membraneUnknownB. infantis[65]PRRs pattern recognition receptors, MAMPs microbial-associated molecular patterns, TLRs toll-like receptors, EGFR epidermal growth factor receptor, DC-SIGN dendritic cell specific intercellular adhesion molecule grabbing nonintegrin, Slp surface layer protein, CPS capsule polysaccharide, NOD nucleotide binding oligomerization domain containing protein, LPS lipopolysaccharide, LTA lipoteichoic acid; p75 and p40, cell wall associated hydrolase, PG peptidoglycan Based on the above mentioned analyses on the potential role of the surface compounds and metabolites of probiotics in gut barrier function, [10–13, 18] this review provides updated and comprehensive information on the molecular interaction between intestinal probiotics and the gut barrier and summarizes the effects of the surface macromolecules and metabolites of probiotics on intestinal receptors and pathways. REGULATION OF INTESTINAL BARRIER FUNCTION BY SURFACE MOLECULES OF PROBIOTICS A number of previous studies have shown that the surface molecules of probiotics including SLPs, flagella, fimbriae and CPS can be recognized by PRRs and play a role in maintaining intestinal homeostasis and promoting gut health (Fig. 2) [13, 14, 16].Fig. 2Effects of surface molecular of probiotics on intestinal epithelial barrier. Flagellin, pili, and CPS can be bind to TIR domain in TLRs, thus interacting with adaptor molecules such as MyD88 to activate AP-1 and NF-κB signaling pathways in IEC. Flagellin of EcN can finally induce the expression of HBD-2 in the gut, which is beneficial for the prevention of pathogens. F1C pili of EcN can finally up-regulate the expression of tight junction to enhance gut barrier function. CPS of EcN can finally induce the secretion of cytokines such as IL-10 and IL-12 for the alleviation of intestinal inflammation. SlpA of Lactobacillus acidophilus can bind to DC-SIGN and increase ERK phosphorylation, which mediates interaction with NF-κB and then reduce the expression level of cell apoptosis. SLPs surface layer proteins, CPS capsular polysaccharide, TLRs toll-like receptors, DC-SIGN dendritic cell specific intercellular adhesion molecule grabbing nonintegrin, NF-κB nuclear factor kappa B, AP-1 activating protein-1, IECs intestinal epithelial cells, ERK extracellular signal-regulated kinase, MAPK mitogen-activated protein kinase, HBD-2 beta-defensin 2 SURFACE LAYER PROTEINS Bacterial surface layers are supramolecular cell envelope structures that are abundant in Archaea and in Gram-negative and Gram-positive bacteria [19, 20]. Chemical analyses of isolated S-layers showed that they are mostly composed of a single species of protein or multiple species of glycoproteins, with apparent relative